Close Menu

Applying It

Publisher Elsevier has announced that it is launching a new open-access journal called Applied and Translational Genomics. "Applied and Translational Genomics has a broad scope and provides a home for high-quality research in the areas that sometimes get caught in between basic research and clinical trials," says Bart Wacek, executive publisher of life sciences at Elsevier, in a statement.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.